More articles from Technological Innovations in Immunology 1

You have accessRestricted access
Analysis of BCR-IgH from genomic DNA with UMI incorporation
Chelsea Berngruber, Wenjing Pan, Miranda Byrne-Steele, Song Li and Jian Han

J Immunol 204 (1 Supplement) 86.54; May 1, 2020,
You have accessRestricted access
Validation of Immunogenicity Assessments for Non-Clinical Toxicology Evaluation
Tiffany Hammonds, Courtni Newsome, Wendy Freebern and Chris Thompson

J Immunol 204 (1 Supplement) 86.57; May 1, 2020,
You have accessRestricted access
Evaluating the WOLF^® Cell Sorter impact on neutrophil viability and activation
Aly Krasny and Jose Morachis

J Immunol 204 (1 Supplement) 86.52; May 1, 2020,
You have accessRestricted access
Adarza’s ZIVA multiplex protein detection platform demonstrates flexibility with custom targets for monitoring both inflammation and anti-drug antibody response
Jon J Schmuke, Michelle Pillers, Ernie Mueller, Matt Cooper, Alun Carter and Ayman Kabakibi

J Immunol 204 (1 Supplement) 86.50; May 1, 2020,
You have accessRestricted access
ViaKrome Fixable Viability Dyes: A new approach to dead cell discrimination for intracellular multicolor flow cytometry application
Nathalie Dupas, Nancy Dempsey, Rita Bowers, Mégane Burgaud and Tewfik Miloud

J Immunol 204 (1 Supplement) 86.56; May 1, 2020,
You have accessRestricted access
Development of two novel microglia-specific monoclonal antibodies to discriminate microglia from other CNS-resident macrophages by flow cytometry
Sonja Petra Zahner, Nicole Wilkinson, Chau Nguyen, Jessica Lynn Ellsworth and Dariusz Stepniak

J Immunol 204 (1 Supplement) 86.53; May 1, 2020,
You have accessRestricted access
Development of a Semi-automated Monocyte Monolayer Assay (MMA) to Determine the Clinical Significance of Red Cell Alloantibodies
Melinda M Dean, Thu V Tran, Yu Ji, Tanya Powley, Yuan Tong Gu, Emilie Sauret and Robert L Flower

J Immunol 204 (1 Supplement) 86.55; May 1, 2020,
You have accessRestricted access
ctDNA for early cancer diagnosis in Pacific Communities
Dianne Sika-Paotonu, Toni Anitelea, Adam Faatoese, Bridie Laing, Ron Puni, Tevita Vaipuna and Parry Guilford

J Immunol 204 (1 Supplement) 86.51; May 1, 2020,
You have accessRestricted access
ClinicoPathological Correlation (CPC) ImmunoTechnologies for Monitoring Lymphotoxin Alpha
Shaghayegh Harbi, Rong Wang, Vahid Dean Harbi, John Kerbawy, Hannah Lui Park and John Gonzales

J Immunol 204 (1 Supplement) 86.58; May 1, 2020,
You have accessRestricted access
Expansion of natural killer cells with optimal killing activity for cancer immunotherapy
Kevin Flynn, Christine A. Goetz, Jamie Van Etten, Christopher Hammerbeck, Li Peng, Neil Lee, Joyce Liang, Daniel O-Reilly, Greg Herr, Thuy Tong, Dave Finkel, Mandy Kubik and Jody L Bonnevier

J Immunol 204 (1 Supplement) 86.14; May 1, 2020,

Main menu

User menu

Search

More articles from Technological Innovations in Immunology 1

Pages

Navigate

For Authors

General Information

Journal Services